Arca
Skip to content
Tools
Tools

MURA: UDP-N-acetylglucosamine 1-carboxyvinyltransferase

Protein in Escherichia coli K-12 that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on MURA, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 1

Approved1

  • Fosfomycin

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        FosfomycinApprovedMeitheal PharmaceuticalsSmall moleculeInhibitorUDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor23

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Randomized, Multicenter, Non-inferiority Trial Comparing the Efficacy of Fosfomycin Versus Fluoroquinolones or Cotrimoxazole as Oral Follow-up Treatment in Febrile Urinary Tract Infections in Men Caused by Susceptible EnterobacteriaFosfomycinPhase 3Not yet recruitingAssistance Publique - Hôpitaux de ParisNov 12, 2026
        Fosfomycin Trometamol Compared With an Alternative Active Antibiotic as Step-down Therapy for the Treatment of Acute Pyelonephritis Due to Escherichia Coli in Elderly Women : a Randomized, Multicenter, Non-inferiority TrialFosfomycinPhase 3Not yet recruitingAssistance Publique - Hôpitaux de ParisNov 10, 2026
        Study of Fosfomycin-containing Antibiotic Regimens for the Treatment of Infective Endocarditis in Clinical PracticeFosfomycin—Not yet recruitingEnte Ospedaliero Ospedali GallieraNov 10, 2026
        Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)FosfomycinPhase 1 / Phase 2RecruitingMetagen Therapeutics, Inc.Nov 3, 2026
        Precision Management of Urinary Tract Symptoms in Older WomenFosfomycinPhase 3RecruitingMegan BradleyJul 7, 2026
        Evaluation of the Excretion of Fosfomycin Into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating WomenFosfomycinPhase 4RecruitingMeitheal Pharmaceuticals, Inc.Jun 1, 2026
        A Study Comparing Infectious Complications After Transperineal Prostate Biopsy With or Without Antibiotic ProphylaxisFosfomycinNot applicableEnrolling by invitationF.D. Roosevelt Teaching Hospital with Policlinic Banska BystricaApr 30, 2026
        Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of CareFosfomycinPhase 4RecruitingUppsala UniversityNov 19, 2025

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1984, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.